BH
Therapeutic Areas
Sensei Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PIKTOR | Endometrial cancer, Breast cancer | Phase 1b (assumed) |
| Solnerstotug (SNS-101) | Advanced solid tumors | Phase 1/2 |
Leadership Team at Sensei Biotherapeutics
AP
Anand Parikh
Chief Operating Officer
CG
Christopher Gerry, J.D.
President & General Counsel
JC
Josiah Craver, CPA
SVP, Finance